UMIN ID: C000000303
Registered date:30/12/2005
Romdomized study to evaluate the renoprotective effects of clarithromycin for diabetic patients with microalbuminuria.
Basic Information
| Recruitment status | |
|---|---|
| Health condition(s) or Problem(s) studied | Diabetic nephropathy |
| Date of first enrollment | 2005/06/01 |
| Target sample size | 40 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | In the clarythromycin group, claruthromycin will be prescribed at 200mg/day. In control group, patients receive ordinary diet/excercise therapy and hypotensive agents including ACE inhibitor and ARB. |
Outcome(s)
| Primary Outcome | Urinary albumin excretion |
|---|---|
| Secondary Outcome | 1.Inflammatory marker |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1.CHF 2.Severe liver and/or kidney dysfunction 3.History of allergic response to drugs |
Related Information
| Primary Sponsor | Okayama university graduate school of medicine, dentistry and pharmaceutical sciences, Department of medicine and clinical science |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Okayama university graduate school of medicine, dentistry and pharmaceutical sciences, Department of medicine and clinical science |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | 086-235-7235 |
| Affiliation | Okayama university graduate school of medicine, dentistry and pharmaceutical sciences Department of medicine and clinical science |
| scientific contact | |
| Name | Kenichi Shikata |
| Address | 2-5-1 Shikata-cho, Okayama, 700-8558, Japan Japan |
| Telephone | 086-235-7235 |
| Affiliation | Okayama university graduate school of medicine, dentistry and pharmaceutical sciences Department of medicine and clinical science |